5th Annual Genome Editing Congress

The SynGen Series UK features 5 outstanding programmes bringing together Europe’s most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine & Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.

We will have over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Our 5th Annual Genome Editing Congress will include over 20 case studies and presentations focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies.

Including 2 interactive streams:

Genome Editing Techniques and Technologies
Therapeutic Applications of Genome Editing

Others Details

Time: 7:30 am to 6:00 pm URL: Brochure: https://go.evvnt.com/395623-3?pid=6581 Artists / Speakers: Lin Wu, Director, Genome Modification Facility, Harvard University, Barry Rosen, Vice President and Senior Scientist, AstraZeneca, Aaron Cheng, Head, Discovery Genome Editing, GlaxoSmithKline, Toni Cathomen, Professor and Director, University of Freiburg, Kristine Freude, Associate Professor, University of Copenhagen